Matt Abernethy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jefferies Global Healthcare Conference on June 5 in New York

Wedbush reiterated their outperform rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a research note published on Wednesday morning, Benzinga reports. Wedbush currently has a $152.00 target price on the stock. NBIX has been the topic of a number of other research reports. Canaccord Genuity Group lifted their price target on shares […]

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) were down 5.3% on Wednesday . The stock traded as low as $132.58 and last traded at $133.02. Approximately 153,432 shares were traded during trading, a decline of 81% from the average daily volume of 812,679 shares. The stock had previously closed at $140.48. Analyst […]

Great Lakes Advisors LLC raised its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 163,485 shares of the company’s stock after purchasing an additional 1,528 shares during the period. Great Lakes Advisors LLC owned about 0.17% […]

Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price objective cut by JPMorgan Chase & Co. from $154.00 to $148.00 in a report published on Friday, Benzinga reports. They currently have an overweight rating on the stock. Several other research analysts have also weighed in on the stock. Raymond James upped their price objective on […]